Do you offer neoadjuvant therapy to a postmenopausal cT1cN0 , HER2+, ER/PR+ breast IDC or recommend surgery first?  


Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Warren Alpert Medical School of Brown University
I would be very hesitant to administer adjuvant T-...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Iowa Holden Comprehensive Cancer Center
I agree with the above comment. When we use neoadj...
Medical Oncologist at Siri Onclogy and hematology Infusion Service
The subset analysis shows questionable benefit for...
Medical Oncologist at Siri Onclogy and hematology Infusion Service
I wished to comment first on the value of this for...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Iowa Holden Comprehensive Cancer Center
I agree with the above answer. We run risk of over...
Sign in or Register to read more